Emily M. Leproust - Sep 5, 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Executive Officer, Director
Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for Emily M. Leproust
Stock symbol
TWST
Transactions as of
Sep 5, 2023
Transactions value $
$0
Form type
4
Date filed
9/7/2023, 04:05 PM
Previous filing
Aug 22, 2023
Next filing
Sep 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +80.9K +32.76% $0.00 328K Sep 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TWST Employee Stock Option (right to buy) 24.4K Sep 5, 2023 Common Stock 0 $5.95 Direct F2
holding TWST Employee Stock Option (right to buy) 151K Sep 5, 2023 Common Stock 0 $8.82 Direct F3
holding TWST Employee Stock Option (right to buy) 267K Sep 5, 2023 Common Stock 0 $26.66 Direct F4
holding TWST Employee Stock Option (right to buy) 131K Sep 5, 2023 Common Stock 0 $23.33 Direct F5
holding TWST Employee Stock Option (right to buy) 65K Sep 5, 2023 Common Stock 0 $67.85 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of September 5, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F5 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.